Sarafloxacin (INN) is a quinolone antibiotic drug, which was removed from clinical use by its manufacturer Abbott Laboratories from April 30, 2001.

See also

  • Quinolone
  • Adverse effects of fluoroquinolones

References



SarafloxacinD8 hydrochloride WITEGA Laboratorien BerlinAdlershof GmbH

Sarafloxacin Stock Illustrations 1 Sarafloxacin Stock Illustrations

Sarafloxacin HCL (Cas No.91296876) C20H18ClF2N3O3 Huavet (China

Salofalk GranuStix 1000mg magensaftresistent 50 stk

MexBsarafloxacin_0